- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-265
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.00 |
Change
-0.190(1.56%) |
Mkt cap ! $266.3M |
Open | High | Low | Value | Volume |
$12.00 | $13.06 | $11.75 | $430.1K | 35.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 333 | $12.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.52 | 403 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 41 | 12.360 |
1 | 2000 | 12.300 |
3 | 5745 | 12.000 |
2 | 5500 | 11.880 |
2 | 520 | 11.600 |
Price($) | Vol. | No. |
---|---|---|
11.640 | 2053 | 2 |
12.700 | 3000 | 1 |
13.000 | 4000 | 2 |
13.300 | 2000 | 1 |
14.300 | 200 | 1 |
Last trade - 15.59pm 02/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |